Steven Bollipo
Overview
Explore the profile of Steven Bollipo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Clark P, Valery P, Ward J, Strasser S, Weltman M, Thompson A, et al.
BMC Gastroenterol
. 2022 Jul;
22(1):339.
PMID: 35820850
Background: First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations...
12.
Khan R, Gimpaya N, Vargas J, Ramkissoon A, Seleq S, Gholami R, et al.
Endoscopy
. 2022 Jun;
55(2):121-128.
PMID: 35642290
BACKGROUND : Assessment of mucosal visualization during esophagogastroduodenoscopy (EGD) can be improved with a standardized scoring system. To address this need, we created the Toronto Upper Gastrointestinal Cleaning Score (TUGCS)....
13.
Clark P, Valery P, Strasser S, Weltman M, Thompson A, Levy M, et al.
Dig Dis Sci
. 2022 May;
68(1):291-303.
PMID: 35552941
Background And Aims: In 2016, direct-acting antiviral (DAA) treatment for hepatitis C (HCV) became available through Australia's universal health care system, with the aim of HCV elimination. We report real-world...
14.
Fouad Y, Palmer M, Chen M, Regev A, Banerjee R, Myers R, et al.
J Clin Transl Hepatol
. 2022 May;
10(2):374-382.
PMID: 35528969
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects a third of the population and is a leading cause of liver-related death. Since no effective treatments exist, novel approaches to drug development...
15.
Duong N, Bollipo S, Repaka A, Sebastian S, Tennyson C, Charabaty A
Frontline Gastroenterol
. 2022 Apr;
12(5):440-443.
PMID: 35401964
No abstract available.
16.
de-Madaria E, Mira J, Carrillo I, Afif W, Ang D, Antelo M, et al.
Lancet Gastroenterol Hepatol
. 2022 Mar;
7(5):485-494.
PMID: 35247318
GASTROSWOT is a strategic analysis of the current and projected states of the different subspecialties in gastroenterology that aims to provide guidance for research, clinical, and financial planning in gastroenterology....
17.
Fouad Y, Dufour J, Zheng M, Bollipo S, Desalegn H, Gronbaek H, et al.
Liver Int
. 2022 Feb;
42(4):742-748.
PMID: 35182007
Polarizing opinions have recently arisen in hepatology on the name and redefinition of fatty liver disease associated with metabolic dysfunction. In spite of growing and robust evidence of the superior...
18.
Advani R, Bollipo S, Charabaty A, Duong N, Bilal M, Siau K, et al.
Dig Dis Sci
. 2022 Feb;
67(5):1712-1717.
PMID: 35122593
No abstract available.
19.
Advani R, Duong N, Bilal M, Grover S, Siau K, Bollipo S, et al.
Dig Dis Sci
. 2022 Feb;
67(5):1707-1711.
PMID: 35122591
No abstract available.
20.
Bruce J, Burns G, Soh W, Nair P, Sherwin S, Fan K, et al.
Brain Behav Immun
. 2022 Jan;
101:335-345.
PMID: 35093492
Functional dyspepsia (FD) affects up to 15% of the population and is characterised by recurring upper gastrointestinal (GI) symptoms occurring in the absence of clinically identifiable pathology. Psychological stress is...